Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients

OBJECTIVES: Focusing on the advanced non-small cell lung cancer (NSCLC) patients without driver mutations can elucidate the clinical impact of COPD on treatment outcomes. The present study evaluated the effects of COPD on the overall survival of driver mutation-negative NSCLC patients undergoing con...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jeong Uk, Yeo, Chang Dong, Rhee, Chin Kook, Kim, Yong Hyun, Park, Chan Kwon, Kim, Ju Sang, Kim, Jin Woo, Kim, Seung Joon, Yoon, Hyoung Kyu, Lee, Sang Haak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047599/
https://www.ncbi.nlm.nih.gov/pubmed/30034229
http://dx.doi.org/10.2147/COPD.S167372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047599/
https://www.ncbi.nlm.nih.gov/pubmed/30034229
http://dx.doi.org/10.2147/COPD.S167372

Ejemplares similares